Boutahar Bendaoud
5 Foch Avenue, BP 824
Brest, 29609, France
Brest, 29609, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia.
Journal: Journal for immunotherapy of cancer
Published: November 02, 2018
Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy.
Journal: Oncotarget
Published: December 28, 2017
Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.
Journal: Clinical reviews in allergy & immunology
Published: May 07, 2017
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up.
Journal: Clinical reviews in allergy & immunology
Published: June 26, 2016
Ofatumumab capacity to deplete B cells from chronic lymphocytic leukaemia is affected by C4 complement exhaustion.
Journal: European journal of haematology
Published: April 22, 2015
Human regulatory B cells control the TFH cell response.
Journal: The Journal of allergy and clinical immunology
Published: February 24, 2015
Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival.
Journal: Journal of autoimmunity
Published: February 04, 2014
Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephritis.
Journal: Clinical kidney journal
Published: July 20, 2012
The complexity of the BAFF TNF-family members: implications for autoimmunity.
Journal: Journal of autoimmunity
Published: May 18, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026